67 related articles for article (PubMed ID: 21595737)
1. Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
Gustafsson K; Junevik K; Werlenius O; Holmgren S; Karlsson-Parra A; Andersson PO
Scand J Immunol; 2011 Sep; 74(3):318-326. PubMed ID: 21595737
[TBL] [Abstract][Full Text] [Related]
2. Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
Zhang M; Ju W; Yao Z; Yu P; Wei BR; Simpson RM; Waitz R; Fassò M; Allison JP; Waldmann TA
J Immunol; 2012 Jun; 188(12):6156-64. PubMed ID: 22593619
[TBL] [Abstract][Full Text] [Related]
3. CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8
Dharmadhikari B; Nickles E; Harfuddin Z; Ishak NDB; Zeng Q; Bertoletti A; Schwarz H
Cancer Immunol Immunother; 2018 Jun; 67(6):893-905. PubMed ID: 29508025
[TBL] [Abstract][Full Text] [Related]
4. Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8+ T cells.
Krueger PD; Narayanan S; Surette FA; Brown MG; Sung SJ; Hahn YS
J Leukoc Biol; 2017 Jan; 101(1):329-338. PubMed ID: 27493244
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues.
Ali A; Canaday LM; Feldman HA; Cevik H; Moran MT; Rajaram S; Lakes N; Tuazon JA; Seelamneni H; Krishnamurthy D; Blass E; Barouch DH; Waggoner SN
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34314390
[TBL] [Abstract][Full Text] [Related]
6. T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil.
Mellstedt H; Choudhury A
Cancer Immunol Immunother; 2006 Feb; 55(2):210-20. PubMed ID: 15906026
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8
Moreno Ayala MA; Campbell TF; Zhang C; Dahan N; Bockman A; Prakash V; Feng L; Sher T; DuPage M
Immunity; 2023 Jul; 56(7):1613-1630.e5. PubMed ID: 37392735
[TBL] [Abstract][Full Text] [Related]
8. T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice.
Oldreive CE; Skowronska A; Davies NJ; Parry H; Agathanggelou A; Krysov S; Packham G; Rudzki Z; Cronin L; Vrzalikova K; Murray P; Odintsova E; Pratt G; Taylor AM; Moss P; Stankovic T
Dis Model Mech; 2015 Nov; 8(11):1401-12. PubMed ID: 26398941
[TBL] [Abstract][Full Text] [Related]
9. Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial.
Tang X; Deng B; Zang A; He X; Zhou Y; Wang D; Li D; Dai X; Chen J; Zhang X; Liu Y; Xu Y; Chen J; Zheng W; Zhang L; Gao C; Yang H; Li B; Wang X
Front Immunol; 2022; 13():940577. PubMed ID: 36248873
[TBL] [Abstract][Full Text] [Related]
10. Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration.
Karlsson-Parra A; Kovacka J; Heimann E; Jorvid M; Zeilemaker S; Longhurst S; Suenaert P
Pharm Res; 2018 Jun; 35(8):156. PubMed ID: 29904904
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions.
Toffoli EC; van Vliet AA; Forbes C; Arns AJ; Verheul HWM; Tuynman J; van der Vliet HJ; Spanholtz J; de Gruijl TD
Clin Exp Immunol; 2024 Apr; 216(2):159-171. PubMed ID: 38330230
[TBL] [Abstract][Full Text] [Related]
12. The polarization of immune cells in the tumour environment by TGFbeta.
Flavell RA; Sanjabi S; Wrzesinski SH; Licona-Limón P
Nat Rev Immunol; 2010 Aug; 10(8):554-67. PubMed ID: 20616810
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CVC1302-Mediated Enhancement of Monocyte Recruitment in Inducing Immune Responses.
Lu H; Yu X; Hou L; Zhang Y; Li L; Qiao X; Cheng H; Du L; Chen J; Zheng Q; Hou J
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250899
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells.
Correa-Lara MVM; Lara-Vega I; Nájera-Martínez M; Domínguez-López ML; Reyes-Maldonado E; Vega-López A
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895943
[TBL] [Abstract][Full Text] [Related]
15. New insights into iNKT cells and their roles in liver diseases.
Gu X; Chu Q; Ma X; Wang J; Chen C; Guan J; Ren Y; Wu S; Zhu H
Front Immunol; 2022; 13():1035950. PubMed ID: 36389715
[TBL] [Abstract][Full Text] [Related]
16. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M
Front Immunol; 2020; 11():594556. PubMed ID: 33312177
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19.
Robb CT; Goepp M; Rossi AG; Yao C
Br J Pharmacol; 2020 Nov; 177(21):4899-4920. PubMed ID: 32700336
[TBL] [Abstract][Full Text] [Related]
18. Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill.
Kristoff J; Rinaldo CR; Mailliard RB
Viruses; 2019 Dec; 12(1):. PubMed ID: 31905690
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment.
Xiao P; Guo Y; Zhang H; Zhang X; Cheng H; Cao Q; Ke Y
Oncogene; 2018 Sep; 37(37):5088-5100. PubMed ID: 29795405
[TBL] [Abstract][Full Text] [Related]
20. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
